SG11201912105PA - Compositions comprising bacterial strains - Google Patents
Compositions comprising bacterial strainsInfo
- Publication number
- SG11201912105PA SG11201912105PA SG11201912105PA SG11201912105PA SG11201912105PA SG 11201912105P A SG11201912105P A SG 11201912105PA SG 11201912105P A SG11201912105P A SG 11201912105PA SG 11201912105P A SG11201912105P A SG 11201912105PA SG 11201912105P A SG11201912105P A SG 11201912105PA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- bacterial strains
- strains
- bacterial
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1709465.7A GB201709465D0 (en) | 2017-06-14 | 2017-06-14 | Compositions comprising bacterial strains |
| GBGB1709526.6A GB201709526D0 (en) | 2017-06-15 | 2017-06-15 | Compositions comprising bacterial strains |
| GBGB1805989.9A GB201805989D0 (en) | 2018-04-11 | 2018-04-11 | Compositions comprising bacterial strains |
| GBGB1805991.5A GB201805991D0 (en) | 2018-04-11 | 2018-04-11 | Compositions comprising bacterial strains |
| GBGB1805990.7A GB201805990D0 (en) | 2018-04-11 | 2018-04-11 | Compostions comprising bacterial strains |
| GBGB1806779.3A GB201806779D0 (en) | 2018-04-25 | 2018-04-25 | Compositions comprising bacterial strains |
| GBGB1806780.1A GB201806780D0 (en) | 2018-04-25 | 2018-04-25 | Compositions comprising bacterial strains |
| PCT/EP2018/065809 WO2018229189A1 (en) | 2017-06-14 | 2018-06-14 | Compositions comprising bacterial strains |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201912105PA true SG11201912105PA (en) | 2020-01-30 |
Family
ID=62631106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201912105PA SG11201912105PA (en) | 2017-06-14 | 2018-06-14 | Compositions comprising bacterial strains |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20200171102A1 (en) |
| EP (2) | EP3858367A1 (en) |
| JP (2) | JP6840272B2 (en) |
| KR (1) | KR102521444B1 (en) |
| CN (2) | CN115813955A (en) |
| AU (2) | AU2018285445B2 (en) |
| BR (1) | BR112019026477A2 (en) |
| CA (1) | CA3066189A1 (en) |
| CY (1) | CY1123857T1 (en) |
| DK (1) | DK3600363T3 (en) |
| ES (1) | ES2855701T3 (en) |
| HR (1) | HRP20210205T1 (en) |
| HU (1) | HUE053488T2 (en) |
| IL (2) | IL283973B (en) |
| LT (1) | LT3600363T (en) |
| MD (1) | MD3600363T2 (en) |
| PL (1) | PL3600363T3 (en) |
| PT (1) | PT3600363T (en) |
| RS (1) | RS61367B1 (en) |
| SG (1) | SG11201912105PA (en) |
| SI (1) | SI3600363T1 (en) |
| TW (1) | TWI767013B (en) |
| WO (1) | WO2018229189A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3600363T (en) * | 2017-06-14 | 2021-02-10 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| HRP20220747T1 (en) | 2017-06-14 | 2022-10-14 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| WO2019215345A1 (en) | 2018-05-11 | 2019-11-14 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| CN112410242A (en) * | 2020-08-25 | 2021-02-26 | 上海市第十人民医院 | Parabacteroides diesei strain separated from rectal cancer tumor tissue and application thereof |
| WO2023001368A1 (en) * | 2021-07-20 | 2023-01-26 | Université Catholique de Louvain | Prevention and/or treatment of reward dysregulation disorders |
| KR20240040089A (en) * | 2021-07-20 | 2024-03-27 | 위니베르시트카솔리끄드루뱅 | Prevention and/or treatment of reward dysregulation |
| CN113750121A (en) * | 2021-08-20 | 2021-12-07 | 上海交通大学医学院附属瑞金医院 | Application of parabacteroides diesei in preparation of medicinal preparation for treating alzheimer disease |
| WO2023164591A2 (en) * | 2022-02-23 | 2023-08-31 | Metagenomi, Inc. | Systems and methods for transposing cargo nucleotide sequences |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ899700A0 (en) * | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
| US20040005304A1 (en) * | 2002-07-08 | 2004-01-08 | Mak Wood, Inc. | Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions |
| WO2008050209A1 (en) | 2006-10-27 | 2008-05-02 | Pfizer Products Inc. | Hydroxypropyl methyl cellulose hard capsules and process of manufacture |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| AU2012322979B2 (en) * | 2011-10-11 | 2017-02-02 | Achim Biotherapeutics Ab | Composition comprising anaerobically cultivated human intestinal microbiota |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| CN104546934B (en) * | 2014-09-30 | 2019-04-09 | 深圳华大基因科技有限公司 | Excrement pair bacteroid is treating or preventing the application in rheumatoid arthritis or its related disease |
| SE1550189A1 (en) * | 2015-02-19 | 2016-08-20 | Achim Biotherapeutics Ab | Therapeutic and prophylactic composition produced by microbiota |
| DK3240554T3 (en) * | 2015-06-15 | 2019-10-28 | 4D Pharma Res Ltd | BLAUTIA STERCOSIS AND WEXLERAE FOR USE IN TREATMENT OF INFLAMMATORY AND AUTO-IMMUNE DISEASES |
| MA41060B1 (en) * | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| IL277648B2 (en) * | 2015-11-03 | 2023-04-01 | Brigham & Womens Hospital Inc | Therapeutic microbiota for the treatment and/or prevention of food allergy |
| JP7216998B2 (en) * | 2016-03-14 | 2023-02-02 | ホロバイオーム， インコーポレイテッド | Modification of the Gut Microbiome to Treat Central Nervous System Psychiatric Disorders or Diseases |
| CA3047397A1 (en) * | 2016-12-20 | 2018-06-28 | The Regents Of The University Of California | Compositions and methods for inhibiting seizures |
| LT3600363T (en) * | 2017-06-14 | 2021-02-10 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| US20210364526A1 (en) * | 2018-05-23 | 2021-11-25 | The Regents Of The University Of California | Methods of selecting subjects for treatment with metabolomic modulators |
-
2018
- 2018-06-14 LT LTEP18731819.1T patent/LT3600363T/en unknown
- 2018-06-14 SI SI201830161T patent/SI3600363T1/en unknown
- 2018-06-14 CN CN202210381608.8A patent/CN115813955A/en active Pending
- 2018-06-14 PT PT187318191T patent/PT3600363T/en unknown
- 2018-06-14 WO PCT/EP2018/065809 patent/WO2018229189A1/en active Search and Examination
- 2018-06-14 IL IL283973A patent/IL283973B/en unknown
- 2018-06-14 EP EP20210763.7A patent/EP3858367A1/en active Pending
- 2018-06-14 BR BR112019026477-9A patent/BR112019026477A2/en unknown
- 2018-06-14 CN CN201880039720.5A patent/CN111107859B/en active Active
- 2018-06-14 AU AU2018285445A patent/AU2018285445B2/en active Active
- 2018-06-14 MD MDE20200143T patent/MD3600363T2/en unknown
- 2018-06-14 JP JP2019567619A patent/JP6840272B2/en active Active
- 2018-06-14 RS RS20210088A patent/RS61367B1/en unknown
- 2018-06-14 HU HUE18731819A patent/HUE053488T2/en unknown
- 2018-06-14 KR KR1020197037443A patent/KR102521444B1/en active IP Right Grant
- 2018-06-14 ES ES18731819T patent/ES2855701T3/en active Active
- 2018-06-14 SG SG11201912105PA patent/SG11201912105PA/en unknown
- 2018-06-14 DK DK18731819.1T patent/DK3600363T3/en active
- 2018-06-14 PL PL18731819T patent/PL3600363T3/en unknown
- 2018-06-14 TW TW107120603A patent/TWI767013B/en active
- 2018-06-14 EP EP18731819.1A patent/EP3600363B1/en active Active
- 2018-06-14 CA CA3066189A patent/CA3066189A1/en not_active Abandoned
-
2019
- 2019-12-03 IL IL271152A patent/IL271152B/en active IP Right Grant
- 2019-12-13 US US16/714,023 patent/US20200171102A1/en active Pending
-
2020
- 2020-06-26 AU AU2020204265A patent/AU2020204265A1/en not_active Abandoned
-
2021
- 2021-02-05 HR HRP20210205TT patent/HRP20210205T1/en unknown
- 2021-02-15 CY CY20211100127T patent/CY1123857T1/en unknown
- 2021-02-16 JP JP2021022774A patent/JP2021080269A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL271319A (en) | Compositions comprising bacterial strains | |
| IL283973A (en) | Compositions comprising bacterial strains | |
| HUE052319T2 (en) | Compositions comprising bacterial strains | |
| SI3630136T1 (en) | Compositions comprising bacterial strains | |
| GB201708182D0 (en) | Compositions comprising bacterial strains | |
| IL272491A (en) | Compositions comprising bacterial strains | |
| GB201718551D0 (en) | Compositions comprising bacterial strains | |
| GB201714298D0 (en) | Compositions comprising bacterial strains | |
| GB201714305D0 (en) | Compositions comprising bacterial strains | |
| GB201714309D0 (en) | Compositions comprising bacterial strains | |
| GB201712851D0 (en) | Compositions comprising bacterial strains | |
| GB201712857D0 (en) | Compositions comprising bacterial strains | |
| GB201709533D0 (en) | Compositions comprising bacterial strains | |
| GB201709526D0 (en) | Compositions comprising bacterial strains | |
| GB201709534D0 (en) | Compositions comprising bacterial strains | |
| GB201709466D0 (en) | Compositions comprising bacterial strains | |
| GB201709465D0 (en) | Compositions comprising bacterial strains | |
| GB201709468D0 (en) | Compositions comprising bacterial strains | |
| GB201708176D0 (en) | Compositions comprising bacterial strains | |
| GB201703552D0 (en) | Compositions comprising bacterial strains | |
| GB201703548D0 (en) | Compositions comprising bacterial strains | |
| GB201604920D0 (en) | Compositions comprising bacterial strains | |
| GB201604566D0 (en) | Compositions comprising bacterial strains | |
| GB201603786D0 (en) | Compositions comprising bacterial strains | |
| GB201603817D0 (en) | Compositions comprising bacterial strains |